메뉴 건너뛰기




Volumn 43, Issue 11, 2010, Pages 1047-1053

Lack of tolerance for the anti-dyskinetic effects of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in rats

Author keywords

7 Nitroindazole; DOPA priming; Dyskinesia; L DOPA; Nitric oxide; Nitric oxide synthase; Parkinson's disease

Indexed keywords

7 NITROINDAZOLE; DOPAMINE; LEVODOPA;

EID: 78649463141     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2010007500111     Document Type: Article
Times cited : (16)

References (40)
  • 2
    • 0026531143 scopus 로고
    • Histochemical mapping of nitric oxide synthase in the rat brain
    • Vincent SR, Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 1992; 46: 755-784.
    • (1992) Neuroscience , vol.46 , pp. 755-784
    • Vincent, S.R.1    Kimura, H.2
  • 3
    • 0035313948 scopus 로고    scopus 로고
    • Nitric oxide: A novel link between synaptic and nonsynaptic transmission
    • Kiss JP, Vizi ES. Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends Neurosci 2001; 24: 211-215.
    • (2001) Trends Neurosci , vol.24 , pp. 211-215
    • Kiss, J.P.1    Vizi, E.S.2
  • 4
    • 45149088480 scopus 로고    scopus 로고
    • Concepts of neural nitric oxide-mediated transmission
    • Garthwaite J. Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 2008; 27: 2783-2802.
    • (2008) Eur J Neurosci , vol.27 , pp. 2783-2802
    • Garthwaite, J.1
  • 7
    • 0037097153 scopus 로고    scopus 로고
    • Regulation of striatal dopamine neurotransmission by nitric oxide: Effector pathways and signaling mechanisms
    • West AR, Galloway MP, Grace AA. Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms. Synapse 2002; 44: 227-245.
    • (2002) Synapse , vol.44 , pp. 227-245
    • West, A.R.1    Galloway, M.P.2    Grace, A.A.3
  • 8
    • 0030847454 scopus 로고    scopus 로고
    • New and potent inhibitors of nitric oxide synthase reduce motor activity in mice
    • Dzoljic E, De Vries R, Dzoljic MR. New and potent inhibitors of nitric oxide synthase reduce motor activity in mice. Behav Brain Res 1997; 87: 209-212.
    • (1997) Behav Brain Res , vol.87 , pp. 209-212
    • Dzoljic, E.1    de Vries, R.2    Dzoljic, M.R.3
  • 9
    • 0028944688 scopus 로고
    • Decreased spontaneous motor activity and startle response in nitric oxide synthase inhibitor-treated rats
    • Sandi C, Venero C, Guaza C. Decreased spontaneous motor activity and startle response in nitric oxide synthase inhibitor-treated rats. Eur J Pharmacol 1995; 277: 89-97.
    • (1995) Eur J Pharmacol , vol.277 , pp. 89-97
    • Sandi, C.1    Venero, C.2    Guaza, C.3
  • 10
    • 0029416823 scopus 로고
    • L-NOARG, an inhibitor of nitric oxide synthase, induces catalepsy in mice
    • Marras RA, Martins AP, Del Bel EA, Guimaraes FS. L-NOARG, an inhibitor of nitric oxide synthase, induces catalepsy in mice. Neuroreport 1995; 7: 158-160.
    • (1995) Neuroreport , vol.7 , pp. 158-160
    • Marras, R.A.1    Martins, A.P.2    del Bel, E.A.3    Guimaraes, F.S.4
  • 11
    • 0033954727 scopus 로고    scopus 로고
    • Sub-chronic inhibition of nitricoxide synthesis modifies haloperidol-induced catalepsy and the number of NADPH-diaphorase neurons in mice
    • Del Bel EA, Guimaraes FS. Sub-chronic inhibition of nitricoxide synthesis modifies haloperidol-induced catalepsy and the number of NADPH-diaphorase neurons in mice. Psychopharmacology 2000; 147: 356-361.
    • (2000) Psychopharmacology , vol.147 , pp. 356-361
    • del Bel, E.A.1    Guimaraes, F.S.2
  • 13
    • 50049087567 scopus 로고    scopus 로고
    • Molecular mechanisms of L-DOPA-induced dyskinesia
    • Jenner P. Molecular mechanisms of L-DOPA-induced dyskinesia. Nat Rev Neurosci 2008; 9: 665-677.
    • (2008) Nat Rev Neurosci , vol.9 , pp. 665-677
    • Jenner, P.1
  • 14
    • 0344052684 scopus 로고    scopus 로고
    • Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys
    • Grondin R, Bedard PJ, Hadj TA, Gregoire L, Mori A, Kase H. Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys. Neurology 1999; 52: 1673-1677.
    • (1999) Neurology , vol.52 , pp. 1673-1677
    • Grondin, R.1    Bedard, P.J.2    Hadj, T.A.3    Gregoire, L.4    Mori, A.5    Kase, H.6
  • 15
    • 9144274541 scopus 로고    scopus 로고
    • Prolongation of levodopa responses by glycineB antagonists in parkinsonian primates
    • Papa SM, Auberson YP, Greenamyre JT. Prolongation of levodopa responses by glycineB antagonists in parkinsonian primates. Ann Neurol 2004; 56: 723-727.
    • (2004) Ann Neurol , vol.56 , pp. 723-727
    • Papa, S.M.1    Auberson, Y.P.2    Greenamyre, J.T.3
  • 16
    • 0029665122 scopus 로고    scopus 로고
    • Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys
    • Papa SM, Chase TN. Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys. Ann Neurol 1996; 39: 574-578.
    • (1996) Ann Neurol , vol.39 , pp. 574-578
    • Papa, S.M.1    Chase, T.N.2
  • 17
    • 62349123821 scopus 로고    scopus 로고
    • Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease
    • Padovan-Neto FE, Echeverry MB, Tumas V, Del-Bel EA. Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease. Neuroscience 2009; 159: 927-935.
    • (2009) Neuroscience , vol.159 , pp. 927-935
    • Padovan-Neto, F.E.1    Echeverry, M.B.2    Tumas, V.3    Del-Bel, E.A.4
  • 18
    • 0031925945 scopus 로고    scopus 로고
    • L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA
    • Cenci MA, Lee CS, Bjorklund A. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur J Neurosci 1998; 10: 2694-2706.
    • (1998) Eur J Neurosci , vol.10 , pp. 2694-2706
    • Cenci, M.A.1    Lee, C.S.2    Bjorklund, A.3
  • 19
    • 0036637271 scopus 로고    scopus 로고
    • Animal models of neurological deficits: How relevant is the rat?
    • Cenci MA, Whishaw IQ, Schallert T. Animal models of neurological deficits: how relevant is the rat? Nat Rev Neurosci 2002; 3: 574-579.
    • (2002) Nat Rev Neurosci , vol.3 , pp. 574-579
    • Cenci, M.A.1    Whishaw, I.Q.2    Schallert, T.3
  • 20
    • 0036459952 scopus 로고    scopus 로고
    • Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease
    • Lundblad M, Andersson M, Winkler C, Kirik D, Wierup N, Cenci MA. Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. Eur J Neurosci 2002; 15: 120-132.
    • (2002) Eur J Neurosci , vol.15 , pp. 120-132
    • Lundblad, M.1    Andersson, M.2    Winkler, C.3    Kirik, D.4    Wierup, N.5    Cenci, M.A.6
  • 21
    • 77953047191 scopus 로고    scopus 로고
    • Tolerance to the cataleptic effect that follows repeated nitric oxide synthase inhibition may be related to functional enzymatic recovery
    • Del-Bel EA, Guimaraes FS, Joca SR, Echeverry MB, Ferreira FR. Tolerance to the cataleptic effect that follows repeated nitric oxide synthase inhibition may be related to functional enzymatic recovery. J Psychopharmacol 2010; 24: 397-405.
    • (2010) J Psychopharmacol , vol.24 , pp. 397-405
    • Del-Bel, E.A.1    Guimaraes, F.S.2    Joca, S.R.3    Echeverry, M.B.4    Ferreira, F.R.5
  • 22
    • 58149359032 scopus 로고    scopus 로고
    • Priming for l-dopa-induced dyskinesia in Parkinson's disease: A feature inherent to the treatment or the disease?
    • Nadjar A, Gerfen CR, Bezard E. Priming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease? Prog Neurobiol 2009; 87: 1-9.
    • (2009) Prog Neurobiol , vol.87 , pp. 1-9
    • Nadjar, A.1    Gerfen, C.R.2    Bezard, E.3
  • 23
    • 0345293217 scopus 로고    scopus 로고
    • Effects of electrolytic and 6-hydroxydopamine lesions of rat nigrostriatal pathway on nitric oxide synthase and nicotinamide adenine dinucleotide phosphate diaphorase
    • Gomes MZ, Del Bel EA. Effects of electrolytic and 6-hydroxydopamine lesions of rat nigrostriatal pathway on nitric oxide synthase and nicotinamide adenine dinucleotide phosphate diaphorase. Brain Res Bull 2003; 62: 107-115.
    • (2003) Brain Res Bull , vol.62 , pp. 107-115
    • Gomes, M.Z.1    del Bel, E.A.2
  • 25
    • 0036070538 scopus 로고    scopus 로고
    • L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: Relation to motor and cellular parameters of nigrostriatal function
    • Winkler C, Kirik D, Bjorklund A, Cenci MA. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis 2002; 10: 165-186.
    • (2002) Neurobiol Dis , vol.10 , pp. 165-186
    • Winkler, C.1    Kirik, D.2    Bjorklund, A.3    Cenci, M.A.4
  • 26
    • 0029064091 scopus 로고
    • Forelimb akinesia in the rat Parkinson model: Differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test
    • Olsson M, Nikkhah G, Bentlage C, Bjorklund A. Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 1995; 15: 3863-3875.
    • (1995) J Neurosci , vol.15 , pp. 3863-3875
    • Olsson, M.1    Nikkhah, G.2    Bentlage, C.3    Bjorklund, A.4
  • 27
    • 0032889986 scopus 로고    scopus 로고
    • Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: Studies on medial forebrain bundle and striatal lesions
    • Chang JW, Wachtel SR, Young D, Kang UJ. Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions. Neuroscience 1999; 88: 617-628.
    • (1999) Neuroscience , vol.88 , pp. 617-628
    • Chang, J.W.1    Wachtel, S.R.2    Young, D.3    Kang, U.J.4
  • 28
    • 40949097682 scopus 로고    scopus 로고
    • A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway
    • Gomes MZ, Raisman-Vozari R, Del Bel EA. A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway. Brain Res 2008; 1203: 160-169.
    • (2008) Brain Res , vol.1203 , pp. 160-169
    • Gomes, M.Z.1    Raisman-Vozari, R.2    del Bel, E.A.3
  • 29
    • 40749157838 scopus 로고    scopus 로고
    • Advances in understanding LDOPA- induced dyskinesia
    • Cenci MA, Lindgren HS. Advances in understanding LDOPA- induced dyskinesia. Curr Opin Neurobiol 2007; 17: 665-671.
    • (2007) Curr Opin Neurobiol , vol.17 , pp. 665-671
    • Cenci, M.A.1    Lindgren, H.S.2
  • 31
    • 0035925693 scopus 로고    scopus 로고
    • Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum
    • Lopez A, Munoz A, Guerra MJ, Labandeira-Garcia JL. Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum. Neuroscience 2001; 103: 639-651.
    • (2001) Neuroscience , vol.103 , pp. 639-651
    • Lopez, A.1    Munoz, A.2    Guerra, M.J.3    Labandeira-Garcia, J.L.4
  • 32
    • 2942541214 scopus 로고    scopus 로고
    • Striatal plasticity and extrapyramidal motor dysfunction
    • Chase TN. Striatal plasticity and extrapyramidal motor dysfunction. Parkinsonism Relat Disord 2004; 10: 305-313.
    • (2004) Parkinsonism Relat Disord , vol.10 , pp. 305-313
    • Chase, T.N.1
  • 33
    • 34248201158 scopus 로고    scopus 로고
    • The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice
    • Chalimoniuk M, Langfort J. The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice. Neurochem Int 2007; 50: 821-833.
    • (2007) Neurochem Int , vol.50 , pp. 821-833
    • Chalimoniuk, M.1    Langfort, J.2
  • 34
    • 33745991786 scopus 로고    scopus 로고
    • Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice
    • Chalimoniuk M, Lukacova N, Marsala J, Langfort J. Alterations of the expression and activity of midbrain nitric oxide synthase and soluble guanylyl cyclase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. Neuroscience 2006; 141: 1033-1046.
    • (2006) Neuroscience , vol.141 , pp. 1033-1046
    • Chalimoniuk, M.1    Lukacova, N.2    Marsala, J.3    Langfort, J.4
  • 35
    • 29344434297 scopus 로고    scopus 로고
    • ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice
    • Pavon N, Martin AB, Mendialdua A, Moratalla R. ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Biol Psychiatry 2006; 59: 64-74.
    • (2006) Biol Psychiatry , vol.59 , pp. 64-74
    • Pavon, N.1    Martin, A.B.2    Mendialdua, A.3    Moratalla, R.4
  • 37
    • 12344276324 scopus 로고    scopus 로고
    • Influence of the therapy with pergolide mesylate plus L-DOPA and with L-DOPA alone on serum cGMP level in PD patients
    • Chalimoniuk M, Stepien A. Influence of the therapy with pergolide mesylate plus L-DOPA and with L-DOPA alone on serum cGMP level in PD patients. Pol J Pharmacol 2004; 56: 647-650.
    • (2004) Pol J Pharmacol , vol.56 , pp. 647-650
    • Chalimoniuk, M.1    Stepien, A.2
  • 38
    • 0032835969 scopus 로고    scopus 로고
    • Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment
    • Cenci MA, Tranberg A, Andersson M, Hilbertson A. Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment. Neuroscience 1999; 94: 515-527.
    • (1999) Neuroscience , vol.94 , pp. 515-527
    • Cenci, M.A.1    Tranberg, A.2    Andersson, M.3    Hilbertson, A.4
  • 39
    • 33244477604 scopus 로고    scopus 로고
    • Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism
    • Sammut S, Dec A, Mitchell D, Linardakis J, Ortiguela M, West AR. Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism. Neuro-0psychopharmacology 2006; 31: 493-505.
    • (2006) Neuro-0psychopharmacology , vol.31 , pp. 493-505
    • Sammut, S.1    Dec, A.2    Mitchell, D.3    Linardakis, J.4    Ortiguela, M.5    West, A.R.6
  • 40
    • 1442300196 scopus 로고    scopus 로고
    • The nitric oxide-guanylyl cyclase signaling pathway modulates membrane activity states and electrophysiological properties of striatal medium spiny neurons recorded in vivo
    • West AR, Grace AA. The nitric oxide-guanylyl cyclase signaling pathway modulates membrane activity states and electrophysiological properties of striatal medium spiny neurons recorded in vivo. J Neurosci 2004; 24: 1924-1935.
    • (2004) J Neurosci , vol.24 , pp. 1924-1935
    • West, A.R.1    Grace, A.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.